ChoudharyHR, ParaiD, DashGC, et al.IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection. Infection, 2021:1–4. https://doi.org/10.1007/s15010-021-01651-4.
2.
HallVJ, FoulkesS, CharlettA, et al.SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). Lancet, 2021; 397:1459–1469.
3.
KrsakM, HarryBL, PalmerBE, and Franco-ParedesC. Postinfectious immunity after COVID-19 and vaccination against SARS-CoV-2. Viral Immunol, 2021; 34:504–509.
4.
KshatriJS, BhattacharyaD, PraharajI, et al.Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys. Epidemiol Infect, 2021; 149:e139.
5.
Ministry of Health and FamilyWelfare, Government of India (COVID-19) Dashboard. https://www.mohfw.gov.in/ (accessed August9, 2021).
6.
SeowJ, GrahamC, MerrickB, et al.Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol, 2020; 5:1598–1607.
